INTERNATIONAL PATENT: ENDOGENEX, INC. FILES APPLICATION FOR "FERRITIN DIRECTED DUODENAL MUCOSAL RECELLURIZATION"

GENEVA, Dec. 31 -- ENDOGENEX, INC. (13755 1st Avenue North, #100Plymouth, Minnesota 55441) filed a patent application (PCT/US2025/034347) for "FERRITIN DIRECTED DUODENAL MUCOSAL RECELLURIZATION" on Jun 19, 2025. With publication no. WO/2025/264907, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABU DAYYEH, Barham K. (c/o ENDOGENEX, INC.13755 1st Avenue North, #100Plymouth, Minnesota 55441), SORLI, Christopher (c/o ENDOGENEX, INC.13755 1st Avenue North, #100Plymouth, Minnesota 55441), CUNNINGHAM, Lian (c/o ENDOGENEX, INC....